IRIS
DEIANA, Giovanni Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.916
AS - Asia 2.858
EU - Europa 2.048
SA - Sud America 1.595
AF - Africa 83
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.819
BR - Brasile 1.423
SG - Singapore 1.143
CN - Cina 936
UA - Ucraina 599
FR - Francia 378
SE - Svezia 299
DE - Germania 262
HK - Hong Kong 243
VN - Vietnam 207
IT - Italia 151
FI - Finlandia 104
GB - Regno Unito 83
AR - Argentina 63
TR - Turchia 50
IN - India 43
MX - Messico 35
IQ - Iraq 34
RU - Federazione Russa 34
ZA - Sudafrica 31
BD - Bangladesh 29
CA - Canada 28
VE - Venezuela 27
UZ - Uzbekistan 24
EC - Ecuador 23
BE - Belgio 22
PL - Polonia 20
JP - Giappone 19
ES - Italia 17
ID - Indonesia 17
NL - Olanda 17
CO - Colombia 16
KR - Corea 16
MA - Marocco 16
CL - Cile 12
PK - Pakistan 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
PY - Paraguay 11
AT - Austria 10
NP - Nepal 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
JO - Giordania 9
PE - Perù 8
UY - Uruguay 8
AU - Australia 7
TN - Tunisia 7
AZ - Azerbaigian 6
HN - Honduras 6
IR - Iran 6
KE - Kenya 6
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
RO - Romania 5
BO - Bolivia 4
EU - Europa 4
GR - Grecia 4
PA - Panama 4
SY - Repubblica araba siriana 4
AL - Albania 3
BW - Botswana 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
IE - Irlanda 2
ME - Montenegro 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
Totale 11.510
Salva come PNG Salva come JPEG
Città #
Dallas 1.628
Singapore 564
Chandler 537
Jacksonville 374
San Jose 315
Hong Kong 241
Ashburn 194
Beijing 191
Princeton 185
Dearborn 162
Nanjing 152
São Paulo 116
Wilmington 93
Lauterbourg 87
Ho Chi Minh City 86
New York 84
Nanchang 69
Shanghai 63
Ann Arbor 60
Boardman 60
Los Angeles 54
Tianjin 42
Hebei 40
Hanoi 39
Shenyang 38
Santa Clara 36
Woodbridge 36
Changsha 33
Rio de Janeiro 33
Belo Horizonte 32
Rome 30
Jiaxing 26
Porto Alegre 25
Sassari 25
Denver 24
Brasília 23
Brussels 22
Baghdad 21
Buffalo 21
Campinas 21
Johannesburg 21
Tashkent 21
Curitiba 20
Munich 19
Jinan 18
Warsaw 18
Tokyo 17
Seoul 16
Bochum 15
Andover 14
Hangzhou 14
Orem 14
Da Nang 13
London 13
Ribeirão Preto 13
Salvador 13
Goiânia 12
Helsinki 12
Mexico City 12
San Francisco 12
Brooklyn 11
Caxias do Sul 11
Dhaka 11
Guangzhou 11
Izmir 11
Kunming 11
Zhengzhou 11
Atlanta 10
Guarulhos 10
Istanbul 10
Chennai 9
Duque de Caxias 9
Frankfurt am Main 9
Ipatinga 9
Montreal 9
Norwalk 9
Sorocaba 9
Toronto 9
Volta Redonda 9
Amman 8
Amsterdam 8
Bauru 8
Campo Grande 8
Canoas 8
Carapicuíba 8
Council Bluffs 8
Dubai 8
Florianópolis 8
Fortaleza 8
Guayaquil 8
Itajaí 8
Manchester 8
Mauá 8
Medellín 8
Montevideo 8
Ningbo 8
Poplar 8
São José dos Campos 8
Brno 7
Haiphong 7
Totale 6.543
Salva come PNG Salva come JPEG
Nome #
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 277
"Erratic" complex partial status epilepticus as a presenting feature of MELAS 207
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 198
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 193
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 192
Acute hyponatremia and neuroleptic malignant syndrome 184
Herv-k modulates the immune response in als patients 181
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 178
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease 173
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 173
A simple capillary electrophoresis method for the analysis of lamotrigine in serum 169
Carbamazepine therapy for steroid psychosis 164
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls 164
Carbamazepine in delayed-onset cerebellar tremor 156
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 154
Brain intgerstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 150
Asterixis and mild encephalopathy induced by gabapentin 150
Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat 148
Beneficial effect of fluoxetine in hyperekplexia 147
Brain interstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 143
Brain interstitial fluid collected trhough implanted tissue cages 141
Reduced intravenous glutathione in the treatment of early Parkinson's disease 138
Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy 138
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 134
Attività epilettogena del tiocolchicoside nell'uomo e nel ratto wistar 132
Brain interstitial fluid collected through implanted tissue cages 131
Carbamazepine in delayed-onset cerebellar tremor 130
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s Disease 129
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 128
Determination of L-alpha aminoadipic acid levels in human and experimental epilepsy 127
Delayedonset cerebellar tremors (DOCT): natural history and treatment 125
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 124
Carbamazepine, clonazepam and focal reflex proprioceptive seizures 123
Expressive aphasia exacerbated by lamotrigine and gabapentin 123
Neuroleptic maglignant syndrome and related syndromes in a neurological popupation 122
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 122
Tache Noire in a Patient with Acute Q Fever 121
Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia 119
Excitatory amino acids in brain interstitial fluid during sustained pentylenetetrazole-induced seizures 118
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 116
Focal e secondarily generalized convulsive status epilepticus induced by thiocolchicoside in the rat 115
Complex partial status epilepticus as presenting features of MELAS: Case report and review of literature 114
Reduced intravenous glutathione in Parkinson's disease 114
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 112
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 112
Increase of alpha-aminoadipate in brain IF during PTZ-induced status epilepticus 110
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazole-induced convulsive status epilepticus 110
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up 108
MuSK antibody-positive, seronegative myasthenia gravis in two sisters 107
Urine bikunin as a marker of renal impairment in Fabry's disease 105
Epileptogenic activity of thiocolchicoside 105
Siti di tremore "rubrale" 105
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies 105
Intravenous glutathione in patients with Parkinson's disease 104
Post-ischemic cerebellar tremors and axonal sprouting in humans 103
Ceruloplasmin and oxidative stress in multiple sclerosis 102
Cerebral and cerebellar diaschisis following carbamazepine therapy 101
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 100
Open study of the activity and tolerability of reduced intravenous glutathione in Parkinson's disease 100
Carbamazepine, clonazepam and focal reflex proprioceptives seizures 99
Ictus giovanile e Malattia di Fabry: lo stato dell’arte in Sardegna 99
Intrathecal overproduction of ceruloplasmin in patients with multiple sclerosis 98
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 97
Cytokines and multiple sclerosis severity: no correlation among Sardinians 97
Risperidone, neuroleptic malignant sindrome and probable dementia with Lewy bodies 96
Non-fluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam 96
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 96
Preliminary experience with fluoxetine in primary focal dystonias 94
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 93
Levetiracetam in stiff-person syndrome 93
Complex partial status epilepticus as presenting feature of MELAS: case report and rewiew of literature 92
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazol-induced convulsive status epilepticus 92
Epilepsy in multiple sclerosis: does predict a worse outcome of disability? 90
Diaschisis, "Rossi -Effect", and antiepileptic action of carbamazepine 90
Encephalopathies related to antiepileptic drugs 89
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 89
Reduced intravenous glutathione in the treatment of early Parkinson’s Disease 88
Neuroleptic malignant syndrome and sudden death after combined zuclopenthixol/trihexiphenidyl withdrawal 88
Successful screening for Fabry disease in patients with juvenile stroke in North Sardinia 88
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation 87
Neurological disorders associated with Mycoplasma pneumoniae infection 86
Status epileptics induced by administration of thiocolchicoside to lithium-pretreated rats 86
Pharmacology of delayed-onset cerebellar tremors 86
Chronic parkinsonism after use of diquat: clinical and MRI studies 86
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 84
Neuroleptic maglignant syndrome and related syndromes in a neurological population 84
Cerebrospinal fluid gamma-glutamyl transpeptidase in multiple sclerosis 84
Pharmacology of delayed-onset cerebellar tremors 82
Delayed-onset cerebellar tremor after stroke 80
Non – fluent spech in patients with partial epilepsy: beneficial effect of levetiracetam 80
Glycosaminoglycans and fabry’s disease 77
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 75
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 74
Discinesie bucco-linguali indotte dal fenobarbitale 72
Multiple sclerosis: correlation between cytokine production and disease progression in Sardinians 72
Familial autoimmune MuSK positive myasthenia gravis 72
Effetti avversi psichiatrici da steroidi e carbamazepina 68
Ceftriaxone has a therapeutic role in Alexander disease 66
Topiramate in patients with cerebellar tremor: a controlled trial 59
Neuroimaging leads to recognition of previously undiagnosed Fabry 47
Totale 11.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022455 95 12 2 19 3 0 21 31 43 17 52 160
2022/20231.070 99 58 9 176 128 196 0 115 194 12 51 32
2023/2024320 54 41 10 8 80 21 2 20 9 7 26 42
2024/20252.834 71 13 177 55 145 68 210 531 1.020 355 104 85
2025/20264.229 175 1.071 772 593 335 243 497 117 187 133 91 15
Totale 11.588